Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
about
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cellsSequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia.Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.Expression of leukemia-associated antigen, JL1, in bone marrow and thymus.Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cellsAcute myeloid leukemia stem cells and CD33-targeted immunotherapyRandomized phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia.Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies.Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinAnti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.
P2860
Q22010987-3B442C9E-6D26-4B96-B072-C4D1FE7755B5Q34268110-F2CEFE8D-D6FB-4588-B341-AFBC0B1690FCQ35146288-8399D141-3480-432B-BDDA-6447D0572E23Q35837399-02A1BEA3-57CA-4505-85DE-0F7146182BF9Q35842009-988D445E-5205-4220-8682-0D56701F67F8Q35895107-DD989D66-078F-4ABF-B854-9F3D6BD535ECQ36058588-A9D3ACE4-8E53-4478-B3B6-50D23468E776Q36498399-C96F71F1-9731-4157-B5C8-8816B06EEFF3Q36579087-5FA39178-3D40-4D89-A132-C89EBF66C048Q36932014-9FFD9410-6025-4736-89E9-44BFF0A4E46BQ37381414-A79A52C1-94D8-4298-A894-E5887CE49280
P2860
Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@en
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@nl
type
label
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@en
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@nl
prefLabel
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@en
Supersaturating infusional hum ...... uM195 in myelogenous leukemia.
@nl
P2093
P1476
Supersaturating infusional hum ...... HuM195 in myelogenous leukemia
@en
P2093
D A Scheinberg
P304
P407
P577
1998-06-01T00:00:00Z